stage IV grade 1 follicular lymphoma
Showing 9976 - 10000 of >10,000
Transforming Ovarian Cancer Diagnostic Pathways
Not yet recruiting
- Ovarian Cancer
-
Birmingham, United Kingdom
- +2 more
Nov 10, 2023
TMJ Pain Trial (Hydrocortisone 2.5%, Diclofenac 1% topical)
Not yet recruiting
- TMJ Pain
- Hydrocortisone 2.5%
- Diclofenac 1% topical
- (no location specified)
Apr 3, 2023
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With
Completed
- Metastatic Colorectal Adenocarcinoma
- Fruquintinib
- +3 more
-
Changsha, Hunan, ChinaHunan Cancer hospital
Sep 2, 2023
Chronic Kidney Disease, End-Stage Renal Disease Trial in San Francisco (Digital Education)
Completed
- Chronic Kidney Disease
- End-Stage Renal Disease
- Digital Education
-
San Francisco, CaliforniaSan Francisco VA Medical Center: Clinical Research Center
Mar 7, 2022
Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)
Completed
- Type 1 Diabetic Nephropathy
- oral sitagliptin supplementation
-
Cairo, EgyptNancy Elbarbary
Nov 2, 2023
Glucagon-like Peptide-1 Receptor Agonists According to Type 2
Recruiting
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Bari, ItalyAzienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023
Determining Molecular Drivers of Radiation Dermatitis
Recruiting
- Breast Cancer
-
Jacksonville, FloridaMayo Clinic
Mar 2, 2022
Squamous Cell Carcinoma of the Head and Neck Trial in Atlanta (VX15/2503, Ipilimumab, Nivolumab)
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- VX15/2503
- +2 more
-
Atlanta, GeorgiaEmory University Hospital Midtown
Mar 2, 2022
NSCLC Trial in Yichang (Sindillimab)
Completed
- Non-small Cell Lung Cancer
-
Yichang, Hubei, ChinaDepartment of Medical Oncology, Central Hospital of Yichang City
Mar 29, 2023
Depression ,Anxiety and Stress Disorders Among Diabetic Assuit
Not yet recruiting
- Diabetes Mellitus
- (no location specified)
Sep 30, 2023
Amyotrophic Lateral Sclerosis Trial in Boston, New York (GM604, Placebo comparator)
Completed
- Amyotrophic Lateral Sclerosis
- GM604
- Placebo comparator
-
Boston, Massachusetts
- +1 more
Apr 23, 2021
Relapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL) Trial in China (TQB2450)
Terminated
- Relapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL)
-
Beijing, Beijing, China
- +17 more
Jan 21, 2021
Atopic Dermatitis (AD) Trial (0.3% OPA-15406 Ointment, 1% OPA-15406 Ointment, 0% OPA-15406 vehicle)
Not yet recruiting
- Atopic Dermatitis (AD)
- 0.3% OPA-15406 Ointment
- +2 more
- (no location specified)
Jan 28, 2023
Intrahepatic Cholangiocarcinoma Trial in GuangZhou (HAIC Combined with Tislelizumab and Apatinib)
Recruiting
- Intrahepatic Cholangiocarcinoma
- HAIC Combined with Tislelizumab and Apatinib
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 4, 2022
Heart Failure, Heart Failure With Reduced Ejection Fraction, Implantable Defibrillator User Trial (OPTIMIZER® Integra CCM-D
Not yet recruiting
- Heart Failure
- +9 more
- OPTIMIZER® Integra CCM-D System (Treatment Arm)
- (no location specified)
May 3, 2023
Post-stroke, Parkinson Disease, Multiple Sclerosis Trial (medical device "Homing" (TecnoBody); medical device "Icone" (Heaxel),
Not yet recruiting
- Post-stroke
- +2 more
- medical device "Homing" (TecnoBody); medical device "Icone" (Heaxel)
- Usual Care
- (no location specified)
Aug 22, 2023
NSCLC Trial in Xi'an (Furmonertinib+cisplating/pemetrexed)
Recruiting
- Non-small Cell Lung Cancer
-
Xi'an, Shannxi, ChinaTangdu Hospital
Jun 20, 2022
Osteoarthritis, Knee Trial in Rudrapur (Autologous adipose tissue derived stromal cells)
Completed
- Osteoarthritis, Knee
- Autologous adipose tissue derived stromal cells
-
Rudrapur, Uttarakhand, IndiaAnupam Hospital
Jul 30, 2022
Septic Arthritis Trial in Hangzhou (two-stage primary total knee arthroplasty with low-dose antibiotics)
Completed
- Septic Arthritis
- two-stage primary total knee arthroplasty with low-dose antibiotics
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jul 31, 2022
Hepatic Inflammation, Fibrosis and Prognosis in CHB and NAFLD
Recruiting
- Chronic Hepatitis b
- Non-alcoholic Fatty Liver Disease
-
Nanjing, ChinaNanjing Drum Tower Hospital
Mar 2, 2023
Osteoarthritis, Knee Trial in Bandar Tun Razak (Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs), Marrow
Recruiting
- Osteoarthritis, Knee
- Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
- Marrow cellution
-
Bandar Tun Razak, Wilayah Persekutuan Kuala Lumpur, MalaysiaHospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia (
Aug 15, 2021
